Artículos por temáticas

Botulinum toxin type A and cervical dystonia: a seven-year follow-up.

Camargo CH, Teive HA, Becker N, Munhoz RP, Werneck LC.

Arq Neuropsiquiatr. 2011 Oct;69(5):745-50.

Mixed results for GPi-DBS in the treatment of cranio-facial and cranio-cervical dystonia symptoms.

Limotai N, Go C, Oyama G, Hwynn N, Zesiewicz T, Foote K, Bhidayasiri R, Malaty I, Zeilman P, Rodriguez R, Okun MS.

J Neurol. 2011 Nov;258(11):2069-74. doi: 10.1007/s00415-011-6075-0.

Molecular pathways in dystonia.

Bragg DC, Armata IA, Nery FC, Breakefield XO, Sharma N.

Neurobiol Dis. 2011 May;42(2):136-47. doi: 10.1016/j.nbd.2010.11.015. Review.

Oromandibular dystonia: a clinical report.

Schneider R, Hoffman HT.

J Prosthet Dent. 2011 Dec;106(6):355-8. doi: 10.1016/S0022-3913(11)60145-5.

Current concepts on the mechanisms of dystonia and the beneficial effects of deep brain stimulation.

Stavrinou LC, Boviatsis EJ, Leonardos A, Panourias IG, Sakas DE.

Cent Eur Neurosurg. 2011 Aug;72(3):144-8. doi: 10.1055/s-0031-1271730. Review.

Diagnosing paroxysmal autonomic instability with dystonia following intracerebral hemorrhage.

Chittiboina P, Nixon M, Nanda A, Guthikonda B.

Neurol India. 2011 Nov-Dec;59(6):906-8. doi: 10.4103/0028-3886.91377. No abstract available.

Concurrence of dystonia 1 and Charcot-Marie-Tooth Neuropathy, type 1 A, in a large family.

Zirn B, Korenke C, Wagner M, Rudnik-Schöneborn S, Müller U.

Mov Disord. 2011 Feb 1;26(2):361-2. doi: 10.1002/mds.23437. No abstract available.

Phenotypic spectrum of musician's dystonia: a task-specific disorder?

Schmidt A, Jabusch HC, Altenmüller E, Enders L, Saunders-Pullman R, Bressman SB, Münchau A, Klein C, Hagenah J.

Mov Disord. 2011 Feb 15;26(3):546-9. doi: 10.1002/mds.23526.

[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].

Yabiku MM, Sartori Jde F, Sarraff EP, Osaki TH, Hossaka SK, Pereira CI, Freitas Wd, Osaki MH, Cariello AJ.

Arq Bras Oftalmol. 2011 Nov-Dec;74(6):414-6. Portuguese.

Prochlorperazine-induced tardive dystonia and its worsening with clozapine in a non-mentally ill patient with migraine.

Mendhekar DN, Andrade C.

Ann Pharmacother. 2011 Apr;45(4):545-6. doi: 10.1345/aph.1P194. No abstract available.

Early-onset primary dystonia.

Robottom BJ, Weiner WJ, Comella CL.

Handb Clin Neurol. 2011;100:465-79. doi: 10.1016/B978-0-444-52014-2.00036-7. Review.

Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia.

Kobayashi K, Lang AE, Hallett M, Lenz FA.

Mov Disord. 2011 Jun;26(7):1348-52. doi: 10.1002/mds.23565.

Impaired sequence learning in dystonia mutation carriers: a genotypic effect.

Carbon M, Argyelan M, Ghilardi MF, Mattis P, Dhawan V, Bressman S, Eidelberg D.

Brain. 2011 May;134(Pt 5):1416-27. doi: 10.1093/brain/awr060.

Animal models of dystonia: Lessons from a mutant rat.

LeDoux MS.

Neurobiol Dis. 2011 May;42(2):152-61. doi: 10.1016/j.nbd.2010.11.006. Review.

Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype.

Clot F, Grabli D, Burbaud P, Aya M, Derkinderen P, Defebvre L, Damier P, Krystkowiak P, Pollak P, Leguern E, San C, Camuzat A, Roze E, Vidailhet M, Durr A, Brice A.

Neurogenetics. 2011 Feb;12(1):87-9. doi: 10.1007/s10048-010-0264-3. No abstract available.